Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20448
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCasan, Joshua Ml-
dc.contributor.authorBarraclough, Allison-
dc.contributor.authorShortt, Jake-
dc.contributor.authorHawkes, Eliza A-
dc.date.accessioned2019-03-14T22:35:10Z-
dc.date.available2019-03-14T22:35:10Z-
dc.date.issued2019-03-
dc.identifier.citationThe Lancet. Haematology 2019; 6(3): e119en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20448-
dc.language.isoeng-
dc.titleDose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Lancet. Haematologyen
dc.identifier.affiliationSchool of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationHaematology Department, Monash Health, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1016/S2352-3026(19)30013-4en
dc.type.contentTexten
dc.identifier.orcid0000-0002-0376-2559en
dc.identifier.pubmedid30824036-
dc.type.austinLetter-
local.name.researcherBarraclough, Allison
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Dec 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.